Prostate Cancer

Study Finds Usual Screening Process Could Miss 10%-20% Of Cases

Published in Cancer Weekly, August 7th, 2001

Urologists caution that the number of tissue samples physicians biopsy for prostate cancer screening may not be enough, nor come from a broad enough area.

Ohio State University researchers tried expanding the number of tissue samples to 12, and found the additional samples yielded evidence of cancer in 10 of the 74 study subjects.

"That's a substantial portion of cancers that would have been missed if we hadn't done a more extensive set of biopsies," said Robert Bahnson, coauthor of the study published in the journal Urologic Oncology and a professor of surgery and chief of urology at OSU.

"Somewhere between 10% and 20% of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-08-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry